| Species : |
CMV |
| Source : |
E.coli |
| Tag : |
Non |
| Protein Length : |
23-117 a.a. |
| Predicted N Terminal : |
Thr23 |
| Form : |
Lyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| Bio-activity : |
Measured by its ability to induce myeloperoxidase release from cytochalasin B-treated human neutrophils. Schröder, J.M. et al. (1987) J. Immunol. 139:3474.The ED50 for this effect is typically 0.3 - 0.6 µg/mL.Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CXCR2.The ED50 for this effect is typically 0.03 - 0.18 µg/mL. |
| Molecular Mass : |
Recombinant CMV UL146 has a calculated MW of 11.1 kDa. |
| Purity : |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
| Reconstitution : |
Reconstitute at 25 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
